1. Balancing needs and resources in medicines delivery The Challenge NOW and into the future Shaun Flanagan, Corporate Pharmaceutical Unit 2. Medicine Supply:Core Principles…
Slide 1Creation of a mechanism for the exchange of knowledge on Clinical Added Value for Orphan Drugs (CAVOD) Meeting EUCERD October 24 th, 2011 Pascale Augé (former Ernst…
Slide 1 1 Rare Diseases and Orphan Medicinal Products Máster en diagnóstico y terapia de las enfermedades raras Josep Torrent-Farnell Universitat Autònoma de Barcelona…
Orphan medicines: DG Enterprise and Industry perspective ICORD February 2005 In this talk Cooperation â a role for the EU Orphan regulation â impact so far Key role of…